BioLineRx Ltd. SEC filings BLRX

BioLineRx Ltd. has 617 filings in SEC EDGAR's recent list, going back to Sep 24, 2010. Its latest annual report, Form 20-F, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 23, 2026. The company's fiscal year ends on December 31.

BioLineRx Ltd. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 23, 2026 Oct 23, 2026
EFFECT Filing Oct 2, 2026 —
424B3 Prospectus Oct 2, 2026 —
F-1 Registration statement (foreign issuer) Sep 25, 2026 —
6-K Current report (foreign issuer) Sep 24, 2026 Sep 24, 2026
6-K Current report (foreign issuer) Sep 10, 2026 Sep 10, 2026
D Filing Sep 9, 2026 —
424B5 Prospectus supplement Aug 31, 2026 —
6-K Current report (foreign issuer) Aug 31, 2026 Aug 31, 2026
6-K Current report (foreign issuer) Aug 31, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 28, 2026 Aug 28, 2025
6-K Current report (foreign issuer) Aug 18, 2026 Aug 18, 2026
6-K Current report (foreign issuer) Jul 8, 2026 Jul 8, 2026
6-K Current report (foreign issuer) May 27, 2026 May 27, 2026
6-K Current report (foreign issuer) May 22, 2026 May 22, 2026
6-K Current report (foreign issuer) May 19, 2026 May 19, 2026
6-K Current report (foreign issuer) Apr 28, 2026 Apr 28, 2026
20-F/A Amended annual report (foreign issuer) Mar 27, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 26, 2026 Mar 26, 2026
6-K Current report (foreign issuer) Mar 23, 2026 Mar 23, 2026
20-F Annual report (foreign issuer) Mar 23, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Feb 23, 2026 Feb 23, 2026
S-8 Employee stock plan registration Jan 23, 2026 —
6-K Current report (foreign issuer) Nov 24, 2025 Nov 24, 2025
6-K Current report (foreign issuer) Nov 17, 2025 Nov 17, 2025
6-K Current report (foreign issuer) Sep 29, 2025 Sep 29, 2025
6-K Current report (foreign issuer) Aug 14, 2025 Jun 30, 2025
424B5 Prospectus supplement Jul 25, 2025 —
6-K Current report (foreign issuer) Jun 30, 2025 Jun 30, 2025
6-K Current report (foreign issuer) May 30, 2025 May 30, 2025
6-K Current report (foreign issuer) May 27, 2025 May 27, 2025
6-K Current report (foreign issuer) May 23, 2025 May 23, 2025
424B5 Prospectus supplement Apr 11, 2025 —
6-K Current report (foreign issuer) Mar 31, 2025 Mar 31, 2025
20-F Annual report (foreign issuer) Mar 31, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Jan 21, 2025 Jan 21, 2025
6-K Current report (foreign issuer) Jan 17, 2025 Jan 17, 2025
6-K Current report (foreign issuer) Jan 7, 2025 Jan 7, 2025
424B5 Prospectus supplement Jan 7, 2025 —
6-K Current report (foreign issuer) Jan 6, 2025 Jan 6, 2025
S-8 Employee stock plan registration Dec 27, 2024 —
6-K Current report (foreign issuer) Nov 25, 2024 Nov 25, 2024
6-K Current report (foreign issuer) Nov 21, 2024 Nov 21, 2024
424B5 Prospectus supplement Nov 21, 2024 —
6-K Current report (foreign issuer) Nov 12, 2024 Nov 12, 2024
6-K Current report (foreign issuer) Nov 5, 2024 Nov 5, 2024
6-K Current report (foreign issuer) Oct 16, 2024 Oct 16, 2024
6-K Current report (foreign issuer) Oct 1, 2024 Oct 1, 2024
6-K Current report (foreign issuer) Aug 19, 2024 Aug 19, 2024
6-K Current report (foreign issuer) Aug 15, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Jun 18, 2024 Jun 18, 2024
6-K Current report (foreign issuer) May 30, 2024 May 30, 2024
6-K Current report (foreign issuer) May 28, 2024 May 28, 2024
6-K Current report (foreign issuer) May 24, 2024 May 24, 2024
6-K Current report (foreign issuer) May 17, 2024 May 17, 2024
6-K Current report (foreign issuer) May 6, 2024 May 6, 2024
6-K Current report (foreign issuer) Apr 17, 2024 Apr 17, 2024
6-K Current report (foreign issuer) Apr 10, 2024 Apr 10, 2024
6-K Current report (foreign issuer) Apr 1, 2024 Apr 1, 2024
424B5 Prospectus supplement Apr 1, 2024 —
20-F/A Amended annual report (foreign issuer) Mar 26, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Mar 26, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 26, 2024 Mar 26, 2024
6-K Current report (foreign issuer) Mar 4, 2024 Mar 4, 2024
6-K Current report (foreign issuer) Feb 28, 2024 Feb 28, 2024
6-K Current report (foreign issuer) Feb 16, 2024 Feb 16, 2024
EFFECT Filing Jan 5, 2024 —
S-8 Employee stock plan registration Dec 29, 2023 —
F-3 Shelf registration (foreign issuer) Dec 29, 2023 —
6-K Current report (foreign issuer) Dec 21, 2023 Dec 21, 2023
6-K Current report (foreign issuer) Dec 12, 2023 Dec 12, 2023
6-K Current report (foreign issuer) Nov 20, 2023 Nov 20, 2023
6-K Current report (foreign issuer) Oct 12, 2023 Oct 12, 2023
6-K Current report (foreign issuer) Sep 28, 2023 Sep 28, 2023
6-K Current report (foreign issuer) Sep 11, 2023 Sep 11, 2023
6-K Current report (foreign issuer) Aug 30, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Aug 30, 2023 Aug 30, 2023
6-K Current report (foreign issuer) Aug 8, 2023 Aug 8, 2023
6-K Current report (foreign issuer) Jul 17, 2023 Jul 17, 2023
6-K Current report (foreign issuer) Jun 23, 2023 Jun 23, 2023
6-K Current report (foreign issuer) May 24, 2023 May 24, 2023
6-K Current report (foreign issuer) Apr 25, 2023 Apr 25, 2023
6-K Current report (foreign issuer) Apr 17, 2023 Apr 17, 2023
20-F Annual report (foreign issuer) Mar 22, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Mar 22, 2023 Mar 22, 2023
6-K Current report (foreign issuer) Mar 6, 2023 Mar 6, 2023
S-8 Employee stock plan registration Jan 20, 2023 —
6-K Current report (foreign issuer) Jan 4, 2023 Jan 4, 2023
6-K Current report (foreign issuer) Dec 20, 2022 Dec 20, 2022
6-K Current report (foreign issuer) Nov 15, 2022 Nov 15, 2022
6-K Current report (foreign issuer) Nov 10, 2022 Nov 10, 2022
6-K Current report (foreign issuer) Nov 4, 2022 Nov 4, 2022
6-K Current report (foreign issuer) Nov 3, 2022 Nov 3, 2022
6-K Current report (foreign issuer) Sep 27, 2022 Sep 27, 2022
6-K Current report (foreign issuer) Sep 21, 2022 Sep 21, 2022
424B5 Prospectus supplement Sep 20, 2022 —
6-K Current report (foreign issuer) Sep 19, 2022 Sep 19, 2022
6-K Current report (foreign issuer) Sep 15, 2022 Sep 15, 2022
6-K Current report (foreign issuer) Sep 12, 2022 Sep 12, 2022
20-F/A Amended annual report (foreign issuer) Sep 9, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Aug 16, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Jul 5, 2022 Jul 5, 2022
6-K Current report (foreign issuer) Jun 28, 2022 Jun 28, 2022
6-K Current report (foreign issuer) Jun 16, 2022 Jun 16, 2022
6-K Current report (foreign issuer) May 27, 2022 May 27, 2022
6-K Current report (foreign issuer) May 11, 2022 May 11, 2022
20-F Annual report (foreign issuer) Mar 16, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Mar 16, 2022 Mar 16, 2022
6-K Current report (foreign issuer) Mar 3, 2022 Mar 3, 2022
6-K Current report (foreign issuer) Jan 24, 2022 Jan 24, 2022
6-K Current report (foreign issuer) Jan 18, 2022 Jan 18, 2022
6-K Current report (foreign issuer) Dec 17, 2021 Dec 17, 2021
6-K Current report (foreign issuer) Dec 15, 2021 Dec 15, 2021
6-K Current report (foreign issuer) Dec 3, 2021 Dec 3, 2021
6-K Current report (foreign issuer) Nov 18, 2021 Nov 18, 2021
6-K Current report (foreign issuer) Nov 4, 2021 Nov 4, 2021
6-K Current report (foreign issuer) Oct 27, 2021 Oct 27, 2021
6-K Current report (foreign issuer) Oct 13, 2021 Oct 13, 2021
CT ORDER Filing Sep 21, 2021 —
6-K Current report (foreign issuer) Sep 3, 2021 Sep 3, 2021
424B5 Prospectus supplement Sep 3, 2021 —
6-K Current report (foreign issuer) Aug 18, 2021 Jun 30, 2021
6-K Current report (foreign issuer) May 26, 2021 May 26, 2021
6-K Current report (foreign issuer) May 4, 2021 May 4, 2021
6-K Current report (foreign issuer) Apr 15, 2021 Apr 15, 2021
6-K Current report (foreign issuer) Apr 5, 2021 Apr 5, 2021
6-K Current report (foreign issuer) Feb 26, 2021 Feb 26, 2021
EFFECT Filing Feb 24, 2021 —
POS AM Filing Feb 23, 2021 —
6-K Current report (foreign issuer) Feb 23, 2021 Feb 23, 2021
20-F Annual report (foreign issuer) Feb 23, 2021 Dec 31, 2020
6-K Current report (foreign issuer) Jan 22, 2021 Jan 22, 2021
6-K Current report (foreign issuer) Jan 21, 2021 Jan 21, 2021
424B5 Prospectus supplement Jan 21, 2021 —
FWP Free writing prospectus Jan 20, 2021 —
FWP Free writing prospectus Jan 19, 2021 —
424B5 Prospectus supplement Jan 19, 2021 —
EFFECT Filing Jan 11, 2021 —
CORRESP Letter to the SEC Jan 11, 2021 —
UPLOAD Letter from the SEC Jan 6, 2021 —
F-3 Shelf registration (foreign issuer) Dec 31, 2020 —
424B5 Prospectus supplement Dec 31, 2020 —
6-K Current report (foreign issuer) Dec 16, 2020 Dec 16, 2020
6-K Current report (foreign issuer) Dec 16, 2020 Dec 16, 2020
6-K Current report (foreign issuer) Nov 23, 2020 Nov 23, 2020
6-K Current report (foreign issuer) Nov 18, 2020 Nov 18, 2020
424B5 Prospectus supplement Nov 13, 2020 —
6-K Current report (foreign issuer) Oct 30, 2020 Oct 30, 2020
6-K Current report (foreign issuer) Oct 29, 2020 Oct 29, 2020
6-K Current report (foreign issuer) Sep 25, 2020 Sep 25, 2020
424B5 Prospectus supplement Sep 25, 2020 —
6-K Current report (foreign issuer) Sep 24, 2020 Sep 24, 2020
6-K Current report (foreign issuer) Aug 19, 2020 Aug 19, 2020
6-K Current report (foreign issuer) Aug 19, 2020 Aug 19, 2020
EFFECT Filing Aug 12, 2020 —
POS AM Filing Aug 7, 2020 —
6-K Current report (foreign issuer) Aug 6, 2020 Jun 30, 2020
EFFECT Filing Jul 2, 2020 —
424B3 Prospectus Jul 2, 2020 —
UPLOAD Letter from the SEC Jul 1, 2020 —
CORRESP Letter to the SEC Jul 1, 2020 —
F-1 Registration statement (foreign issuer) Jun 26, 2020 —
D Filing Jun 10, 2020 —
D Filing Jun 10, 2020 —
424B5 Prospectus supplement Jun 3, 2020 —
6-K Current report (foreign issuer) Jun 3, 2020 Jun 3, 2020
6-K Current report (foreign issuer) Jun 1, 2020 Jun 1, 2020
424B5 Prospectus supplement May 28, 2020 —
6-K Current report (foreign issuer) May 28, 2020 May 28, 2020
6-K Current report (foreign issuer) May 27, 2020 May 27, 2020
6-K Current report (foreign issuer) May 26, 2020 May 26, 2020
6-K Current report (foreign issuer) May 26, 2020 May 26, 2020
6-K Current report (foreign issuer) May 20, 2020 May 20, 2020
424B5 Prospectus supplement Apr 17, 2020 —
CT ORDER Filing Mar 23, 2020 —
20-F Annual report (foreign issuer) Mar 12, 2020 Dec 31, 2019
6-K Current report (foreign issuer) Mar 12, 2020 Mar 12, 2020
6-K Current report (foreign issuer) Mar 5, 2020 Mar 5, 2020
6-K Current report (foreign issuer) Feb 27, 2020 Feb 27, 2020
CT ORDER Filing Feb 19, 2020 —
6-K Current report (foreign issuer) Jan 30, 2020 Jan 30, 2020
6-K Current report (foreign issuer) Jan 22, 2020 Jan 22, 2020
6-K Current report (foreign issuer) Jan 14, 2020 Jan 14, 2020
CT ORDER Filing Dec 13, 2019 —
6-K Current report (foreign issuer) Dec 13, 2019 Dec 13, 2019
6-K Current report (foreign issuer) Dec 5, 2019 Dec 5, 2019
6-K Current report (foreign issuer) Nov 12, 2019 Nov 12, 2019
6-K Current report (foreign issuer) Nov 5, 2019 Nov 5, 2019
6-K Current report (foreign issuer) Nov 5, 2019 Nov 5, 2019
6-K Current report (foreign issuer) Sep 25, 2019 Sep 25, 2019
6-K Current report (foreign issuer) Sep 3, 2019 Sep 3, 2019
6-K Current report (foreign issuer) Aug 6, 2019 Jun 30, 2019
20-F/A Amended annual report (foreign issuer) Jul 30, 2019 Dec 31, 2018
6-K Current report (foreign issuer) Jul 2, 2019 Jul 2, 2019
6-K Current report (foreign issuer) Jun 28, 2019 Jun 28, 2019
20-F/A Amended annual report (foreign issuer) Jun 5, 2019 Dec 31, 2018
6-K Current report (foreign issuer) May 28, 2019 May 28, 2019
CT ORDER Filing May 20, 2019 —
6-K Current report (foreign issuer) May 14, 2019 May 14, 2019
6-K Current report (foreign issuer) May 7, 2019 May 7, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BLRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Modi-In
SEC filer status
Non-accelerated filer
SEC CIK
1498403

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.